SCRS Sites Directory

Search SCRS member sites. Discover current trials.

Icon Cancer Foundation

Icon Cancer Foundation is dedicated to improving patient access to medication through clinical trials.

Icon Cancer Foundation (ICF) is the research partner for the Icon Group. ICF conducts Phase I-IV trials across haematology, medical oncology and radiation oncology and is involved in both national and international trials. A portion of our trials are sponsored by the pharmaceutical industry while others are driven by ICF doctors and nurses. We also participate in collaborative group studies and contribute to national registries for various cancer types. Currently, ICF conducts clinical trials across Queensland, including regional areas, with the support of our partner organisations Icon Cancer Care and Radiation Oncology Centres [ROC]. ICF is continually expanding and will soon offer clinical trials in NSW and Western Australia. We have commenced the management of radiation oncology research in to Victoria. As a not-for-profit organisation, ICF relies on a combination of funding sources, including donations, to contribute towards the costs of our collaborative group trials and investigator supported research. Donations also help us provide support to our patients who might not otherwise be able to participate in clinical trials.  


Demographic Data

  • Start year clinical research1990
  • Phases of clinical studiesPhase I, Phase II, Phase III, Phase IV
  • Types of studiesBiologics, Drugs, Vaccines
  • PopulationsAdult 18-64 yrs, Senior 65 yrs and over
  • Type of sitePart of a practice
  • # of employees involved in research30
  • # of investigators42
  • Number of studies last year33
  • Days openMonday, Tuesday, Wednesday, Thursday, Friday
  • Extended office hoursYes
  • Dry iceYes
  • Blinded pharmacistYes
  • Dedicated monitoring spaceYes
  • Internet access for the monitorYes
  • Onsite laboratoryYes
  • Central laboratoryYes
  • Infusion capabilityYes
  • Shipping optionsFedEx, UPS, DHL
  • Contact for regulatory documentsJane Holt
  • Regulatory phone number+61737374558
  • # of days to turn around regulatory documents7 days
  • Type of IRB used by this siteCentral
  • How often does your local IRB meet?Weekly
  • Appropriate storage facilities for productYes
  • Able to appropriately store Schedule II drugsYes
  • # days to turn around budget and contract7 days